Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide adjunctive therapy in pediatric partial-onset seizures
NCT01921205Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of lacosamide in epilepsy, sponsored by UCB. Started Aug 2013; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01921205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01921205.